Real-World Physician Experience on the Effectiveness of WillfortTM Drops in Anemic Patients: A Post-Marketing Survey
DOI:
https://doi.org/10.48165/ahr.2026.11.2.2Keywords:
Anemia, Fatigue, Hematinic support, Real-world evidence, Physician survey, Homeopathic formulation, Constitutional weakness, WillfortAbstract
Introduction: Anemia is a highly prevalent hematological condition associated with fatigue, weakness, pallor, reduced stamina, impaired concentration, and diminished quality of life. Despite the availability of conventional therapies, concerns regarding compliance, and recurrence have increased interest in integrative supportive approaches. The present study aimed to evaluate the real-world effectiveness, speed of action, and physician recommendation of WillfortTM in the management of anemia-associated symptoms. Methods & Methods: A structured Microsoft Forms survey was designed to collect feedback from the market (Consumers, Pharmacist & Physicians). The questionnaire assessed speed of action, and clinical effectiveness using a 5-point rating scale, and recommendation patterns. Overall the data was obtained from 53 respondents. Out of this, 46 are prescribing physicians, others being whose responses were taken into consideration for descriptive analysis. Results: Regarding speed of action, 30.4% of physicians reported immediate improvement (score 5), while 26.1% observed symptomatic benefit within 15 days (score 4); overall, 80.4% reported improvement within 4 weeks. In terms of effectiveness, 47.8% of physicians assigned the highest rating of 5, and 34.8% rated the formulation 4; overall, 82.6% rated the product 4 or 5, indicating positive therapeutic benefit. Additionally, 95.7% of physicians expressed willingness to recommend the formulation to fellow practitioners, reflecting substantial clinical confidence in its utility for anemia-associated complaints. Conclusion: Real-world physician feedback suggests that WillfortTM is clinically useful and immensely beneficial in symptomatic improvement of anemia associated conditions in routine practice. The findings confirm its potential role as a supportive integrative formulation for managing fatigue, weakness, pallor, reduced stamina, and related constitutional symptoms. Further prospective controlled clinical studies with objective hematological parameters are warranted to strengthen the evidence base.
References
World Health Organization. Anaemia. Geneva: World Health Organization; 2021.
Longo DL, Camaschella C. Iron-deficiency anemia. N Engl J Med. 2015 May 7;372(19):1832–1843.
Kassebaum NJ, Jasrasaria R, Naghavi M, Wulf SK, Johns N, Lozano R, Regan M, Weatherall D, Chou DP, Eisele TP, Flaxman SR. A systematic analysis of global anemia burden from 1990 to 2010. Blood. 2014 Jan 30;123(5):615–624.
Tolkien Z, Stecher L, Mander AP, Pereira DI, Powell JJ. Ferrous sulfate supplementation causes significant gastrointestinal side-effects in adults: a systematic review and meta-analysis. PLoS One. 2015 Feb 20;10(2):e0117383.
Clifford T, Howatson G, West DJ, Stevenson EJ. The potential benefits of red beetroot supplementation in health and disease. Nutrients. 2015 Apr 14;7(4):2801–2822.
Boericke W. New Manual of Homoeopathic Materia Medica & Repertory [with Relationship of Remedies]. 2nd re-augmented and revised ed. New Delhi: B. Jain Publishers; 2002.
Clarke JH. Dictionary of Practical Materia Medica. Reprint ed. New Delhi: B. Jain Publishers; 1992.
The Effect of Beet Juice Intake on Increasing Hemoglobin Levels in Adolescent Girls with Anemia: A Literature Review. Jurnal Kebidanan dan Kesehatan Tradisional. 2025;9(2):79–89. doi:10.37341/jkkt.v9i2.664.
Pratiwi AC, Sulastri S. The effect of beetroot juice administration on hemoglobin levels in pregnant women with anemia in the Grabag 1 Public Health Center Area, Magelang Regency. Eduvest-Journal of Universal Studies. 2025 Feb 20;5(2):1791–1803.
Khalid S, Alam SM, Hassan SS, Ahmad SN, Zehra D, Imran-ul-Haq HS. Effects of beetroot (Beta vulgaris) supplements on selective enzymatic and non-enzymatic antioxidants in iron deficiency anemia. Pak J Pharm Sci. 2024 Jul;37(4).
Sathi A, Viswanad V, Aneesh TP, Kumar BA. Pros and cons of phospholipid asymmetry in erythrocytes. J Pharm Bioallied Sci. 2014;6(2):81–85. doi:10.4103/0975-7406.129171.
Rehder D. Vanadium: Its role for humans. In: Sigel A, Sigel H, Sigel RK, editors. Interrelations Between Essential Metal Ions and Human Diseases. Dordrecht: Springer; 2013. p. 139–169.
Pessoa JC, Etcheverry S, Gambino D. Vanadium compounds in medicine. Coord Chem Rev. 2015 Oct 15;301:24–48.
